• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TELEFLEX MEDICAL TELEFLEX AUTOFUSER; PUMP, INFUSION, ELASTOMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TELEFLEX MEDICAL TELEFLEX AUTOFUSER; PUMP, INFUSION, ELASTOMERIC Back to Search Results
Device Problem Use of Device Problem (1670)
Patient Problems Dyspnea (1816); Pain (1994); Discomfort (2330); Numbness (2415); Cough (4457); Cramp(s) /Muscle Spasm(s) (4521)
Event Date 04/23/2023
Event Type  Injury  
Event Description
I was given a arrow teleflex auto fuser containing ropivicaine.I noticed shortness of breath which i was told was not a real symptom prior to use.It felt like my diaphragm was not moving properly.This continued for the 3 days i used the device.I finally stopped use due to the discomfort in my chest.I began heavy coughing about 2 hours after stopping.Coughing up a lot of sticky mucus.The installation of the device has also caused significant pain and muscle pain and spasm in my neck.I would never allow it's use on me again.Oxycodone or similar would have been fine and much less invasive and damaging.The medication caused numbness and pain in my hand that became serious at the "6" setting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TELEFLEX AUTOFUSER
Type of Device
PUMP, INFUSION, ELASTOMERIC
Manufacturer (Section D)
TELEFLEX MEDICAL
MDR Report Key16818259
MDR Text Key314109760
Report NumberMW5117069
Device Sequence Number1
Product Code MEB
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 04/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/25/2023
Patient Sequence Number1
Treatment
ASPIRIN 81 MG; B12.; BYSTOLIC.; DOXSOCIN.; PRAULENT.; PREVACID.; ROPIVACAINE
Patient Outcome(s) Other;
Patient Age79 YR
Patient SexMale
Patient Weight81 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-